KBLB Stock Chart & Stats
$0.14
<$0.01(3.62%)
At close: 4:00 PM EST
$0.14
<$0.01(3.62%)
Day’s Range― - ―
52-Week Range$0.07 - $0.16
Previous CloseN/A
Volume517.16K
Average Volume (3M)1.34M
Market Cap
$123.44M
Enterprise Value$121.19M
Total Cash (Recent Filing)$2.89M
Total Debt (Recent Filing)$1.65M
Price to Earnings (P/E)―
Beta0.37
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,113,049,400
10 Day Avg. Volume971,781
30 Day Avg. Volume1,336,102
Financial Highlights & Ratios
PEG Ratio-8.30
Price to Book (P/B)-11.32
Price to Sales (P/S)0.00
P/FCF Ratio-50.48
Enterprise Value/Market Cap0.98
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-4.72K
Enterprise Value/Ebitda-35.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kraig Biocraft Laboratories News
KBLB FAQ
What was Kraig Biocraft Laboratories Inc’s price range in the past 12 months?
Kraig Biocraft Laboratories Inc lowest stock price was $0.07 and its highest was $0.16 in the past 12 months.
What is Kraig Biocraft Laboratories Inc’s market cap?
Kraig Biocraft Laboratories Inc’s market cap is $123.44M.
When is Kraig Biocraft Laboratories Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kraig Biocraft Laboratories Inc’s earnings last quarter?
Currently, no data Available
Is Kraig Biocraft Laboratories Inc overvalued?
According to Wall Street analysts Kraig Biocraft Laboratories Inc’s price is currently Overvalued.
Does Kraig Biocraft Laboratories Inc pay dividends?
Kraig Biocraft Laboratories Inc does not currently pay dividends.
What is Kraig Biocraft Laboratories Inc’s EPS estimate?
Kraig Biocraft Laboratories Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kraig Biocraft Laboratories Inc have?
Kraig Biocraft Laboratories Inc has 1,113,049,400 shares outstanding.
What happened to Kraig Biocraft Laboratories Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kraig Biocraft Laboratories Inc?
Currently, no hedge funds are holding shares in KBLB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kraig Biocraft Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.12%
12-Months-Change
Fundamentals
Return on Equity
50.38%
Trailing 12-Months
Asset Growth
182.80%
Trailing 12-Months
Company Description
Kraig Biocraft Laboratories Inc
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; military and police for its ballistic protection; and geotextiles, safe and protective clothing, textiles used in transportation and buildings, and functional and sportive textiles. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Technical Analysis
Core Molding Technologies
―
Flexible Solutions International
―
Northern Technologies International
―
―
Loop Industries
―
Ownership Overview
― Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---

